Fast Growing Stocks With High Insider Ownership

Results

170

7 new

Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.

170 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
CORT
US$114.4920.1%65.9%US$12.8bUS$135.25228.044.8%n/aPharmaceuticals & Biotech
APP
US$395.901.0%4.4%US$135.7bUS$654.6034.021.7%n/aSoftware
CBRS
US$198.71-0.2%n/aUS$46.0bUS$292.00460.673.7%n/aSemiconductors
UPST
US$27.441.9%-65.4%US$2.6bUS$39.8053.259.9%n/aDiversified Financials
KRMN
US$48.151.5%-4.1%US$6.3bUS$102.00213.052.6%n/aCapital Goods
UXIN
US$1.39-7.3%-62.1%US$308.0mUS$4.000.569.4%n/aRetail
SMCI
US$28.40-5.6%-49.9%US$17.9bUS$37.8114.722.4%n/aTech
EROC
US$10.26-6.3%n/aUS$2.7bUS$22.632.656.3%n/aCapital Goods
IREN
US$36.80-0.7%139.0%US$13.7bUS$81.7383.241.2%n/aSoftware
FRMM
US$5.16-9.9%-85.4%US$70.9mUS$9.507.2127.7%n/aPharmaceuticals & Biotech
KVHI
US$9.262.2%76.4%US$180.7mn/a1.5146.1%n/aTech
LSF
US$4.16-1.0%-40.6%US$46.2mUS$5.170.9115.9%n/aFood, Beverage & Tobacco
FIGR
US$24.91-9.7%n/aUS$5.7bUS$51.0051.153.0%n/aDiversified Financials
ABEO
US$6.426.1%-1.1%US$368.8mUS$19.715.532.9%n/aPharmaceuticals & Biotech
OSTX
US$1.520%-13.1%US$69.5mUS$8.92-1.953.5%n/aPharmaceuticals & Biotech
QTI
US$2.69-2.9%-48.8%US$37.2mUS$11.601.6104.2%n/aHealthcare
FSUN
US$38.6812.1%11.0%US$1.9bUS$44.751.098.3%n/aBanks
EH
US$5.134.7%-69.6%US$392.9mUS$11.426.369.1%n/aCapital Goods
YSS
US$14.73-13.7%n/aUS$2.0bUS$33.444.9103.3%n/aCapital Goods
HSAI
US$16.9015.8%-9.8%US$2.6bUS$29.9237.927.4%n/aAutomobiles
TEM
New
US$43.872.8%-20.1%US$7.9bUS$65.645.548.2%n/aPharmaceuticals & Biotech
ALOY
US$8.7825.0%24.0%US$606.3mUS$17.00401.077.0%n/aMaterials
ONON
US$36.241.2%-22.9%US$12.3bUS$52.4438.723.2%n/aConsumer Durables
ZS
US$151.206.2%-46.1%US$24.0bUS$192.557.748.2%n/aSoftware
Page 1 of 5